Vision Point Advisory Group, LLC Bristol Myers Squibb CO Transaction History
Vision Point Advisory Group, LLC
- $265 Million
- Q1 2025
A detailed history of Vision Point Advisory Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Vision Point Advisory Group, LLC holds 26,604 shares of BMY stock, worth $1.3 Million. This represents 0.61% of its overall portfolio holdings.
Number of Shares
26,604
Previous 25,677
3.61%
Holding current value
$1.3 Million
Previous $1.45 Million
11.71%
% of portfolio
0.61%
Previous 0.55%
Shares
12 transactions
Others Institutions Holding BMY
# of Institutions
2,809Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.34 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.74 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.27 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.63 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.24 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $104B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...